Acquired demyelinating diseases

Àlex Rovira, Kelly K. Koeller

Research output: Chapter in BookChapterResearchpeer-review

Abstract

© Springer International Publishing Switzerland 2016. Demyelinating disorders of the central nervous system (CNS) have a variety of etiologies and can be separated into primary (e.g., multiple sclerosis (MS) and other idiopathic inflammatory-demyelinating diseases) and secondary (e.g., infectious, ischemic, metabolic, or toxic) diseases. Brain and spinal cord magnetic resonance imaging (MRI) is the imaging modality of choice to assess demyelinating disorders and, together with the clinical and laboratory findings, can accurately classify them in most cases [1-3]. This review will highlight the important imaging manifestations of some acquired demyelinating diseases that allow more specific diagnosis.
Original languageEnglish
Title of host publicationDiseases of the Brain, Head and Neck, Spine 2016-2019: Diagnostic Imaging
Pages59-70
Number of pages11
DOIs
Publication statusPublished - 1 Jan 2016

Keywords

  • ADEM
  • Acquired
  • Brain
  • Chemotherapy
  • Demyelinating diseases
  • Diagnosis
  • Ischemia
  • MR imaging
  • Metabolic diseases
  • Multiple sclerosis
  • NMO
  • Radiotherapy
  • White matter

Fingerprint

Dive into the research topics of 'Acquired demyelinating diseases'. Together they form a unique fingerprint.

Cite this